Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

10.98USD
20 Mar 2019
Change (% chg)

$0.15 (+1.39%)
Prev Close
$10.83
Open
$10.84
Day's High
$11.11
Day's Low
$10.84
Volume
14,879
Avg. Vol
175,535
52-wk High
$34.44
52-wk Low
$9.38

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 11.47 -0.715
Sep '18 12.51 -0.534
Jun '18 21.34 -0.345
Mar '18 14.18 -0.401
FY 2017 Dec '17 27.07 -0.653
Sep '17 24.14 -0.277
Jun '17 8.75 -0.686
Mar '17 11.65 -0.226
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 9 12.87 18.50 6.25 18.50
Quarter Ending Jun-19 9 15.67 31.25 8.00 18.50
Year Ending Dec-19 10 60.88 80.00 32.00 77.04
Year Ending Dec-20 9 61.28 103.21 0.00 102.90
Earnings (per share)
Quarter Ending Mar-19 10 -0.51 -0.41 -0.70 -0.39
Quarter Ending Jun-19 10 -0.49 -0.20 -0.68 -0.41
Year Ending Dec-19 11 -2.21 -1.87 -3.32 -2.08
Year Ending Dec-20 11 -2.69 -1.99 -5.46 -2.32
LT Growth Rate (%) 1 -0.90 -0.90 -0.90 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.32 32.54
P/E High - Last 5 Yrs. -- 147.72 48.15
P/E Low - Last 5 Yrs. -- 47.95 23.42
Beta -- 1.08 0.87
Price to Sales (TTM) 26.31 49.53 8.39
Price to Book (MRQ) 15.16 10.19 5.27
Price to Tangible Book (MRQ) 16.00 13.77 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions 76.32 3.74 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.01 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 182.87 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago 225.95 48.72 8.02
Sales - 5 Yr. Growth Rate -- 22.78 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -74.65 75.14 47.68
EPS (TTM) vs TTM 1 Yr. Ago -3.77 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.47
Capital Spending - 5 Yr. Growth Rate -- 9.12 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) 5.62 3.50 2.98
LT Debt to Equity (MRQ) 0.00 19.49 11.35
Total Debt to Equity (MRQ) 0.00 32.17 16.02
Interest Coverage (TTM) -- -43.13 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.25 52.41
Gross Margin - 5 Yr. Avg. -- 60.46 50.39
EBITD Margin (TTM) -203.90 -- --
EBITD - 5 Yr. Avg -- -110.47 12.43
Operating Margin (TTM) -209.53 -185.04 5.77
Operating Margin - 5 Yr. Avg. -- -126.95 8.02
Pre-Tax Margin (TTM) -206.33 -175.74 4.80
Pre-Tax Margin - 5 Yr. Avg. -- -132.74 8.31
Net Profit Margin (TTM) -206.33 -182.46 1.53
Net Profit Margin - 5 Yr. Avg. -- -137.13 4.72
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 386,295 7,655,536 820,340,930
Net Income/Employee (TTM) -797,026 513,853 92,858,387
Receivable Turnover (TTM) 103.37 6.23 5.82
Inventory Turnover (TTM) -- 1.89 3.41
Asset Turnover (TTM) 0.11 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -22.25 6.36 10.60
Return on Assets - 5 Yr. Avg. -- 5.46 11.78
Return on Investment (TTM) -26.13 8.89 13.82
Return on Investment - 5 Yr. Avg. -- 6.77 15.32
Return on Equity (TTM) -81.04 10.00 15.25
Return on Equity - 5 Yr. Avg. -- 8.29 16.41
  1 Year 3 Year 5 Year
Sales % 95.06 156.83 --
EPS (TTM) % 66.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CytomX Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 25.29 20.97 99 99
13 Week 32.88 26.41 99 95
26 Week 25.44 15.90 99 98
52 Week 39.97 18.64 99 71
YTD 95.63 71.81 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 86.51%
# of Holders: 176
Total Shares Held: 39,027,499
3 Mo. Net Change: 68,047
# New Positions: 17
# Closed Positions: 33
# Increased Positions: 69
# Reduced Positions: 88
# Net Buyers: -19
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.